🔗 Share this article

This year's prestigious award in medical science was awarded for revolutionary findings that clarify how the body's defense network attacks harmful pathogens while sparing the healthy tissues.

Three esteemed researchers—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—share this honor.

The research uncovered specialized "sentinels" within the immune system that remove malfunctioning defense cells capable of harming the organism.

These findings are now paving the way for innovative therapies for autoimmune diseases and cancer.

These laureates will share a monetary award worth 11 million Swedish kronor.

Decisive Discoveries

"Their work has been essential for comprehending how the immune system functions and why we do not all suffer from severe autoimmune diseases," commented the head of the award panel.

The team's research address a fundamental mystery: In what way does the immune system protect us from countless invaders while keeping our healthy cells intact?

Our immune system uses immune cells that scan for indicators of disease, even pathogens and bacteria it has never encountered.

Such cells employ detectors—known as recognition units—that are produced randomly in a vast number of combinations.

That provides the defense network the capacity to combat a wide array of invaders, but the randomness of the mechanism unavoidably produces white blood cells that can target the host.

Security Guards of the Immune System

Researchers previously knew that a portion of these harmful defense cells were eliminated in the thymus—the site where white blood cells develop.

This year's award recognizes the identification of regulatory T-cells—known as the body's "peacekeepers"—which travel through the system to disarm any immune cells that assault the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee added, "The discoveries have laid the foundation for a novel area of research and spurred the development of new therapies, for example for tumors and immune disorders."

Regarding cancer, T-regs block the body from fighting the tumor, so studies are focused on lowering their numbers.

For autoimmune diseases, trials are exploring boosting regulatory T-cells so the body is not being harmed. A comparable method could also be useful in minimizing the chances of organ transplant rejection.

Innovative Experiments

Prof Sakaguchi, of Osaka University, conducted experiments on mice that had their thymus removed, leading to self-attack conditions.

He demonstrated that introducing immune cells from healthy mice could prevent the illness—implying there was a mechanism for preventing immune cells from harming the body.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were studying an genetic autoimmune disease in mice and humans that resulted in the discovery of a genetic factor vital for how regulatory T-cells function.

"The groundbreaking research has revealed how the immune system is controlled by regulatory T cells, preventing it from accidentally targeting the healthy cells," commented a leading physiology specialist.

"The research is a remarkable example of how basic physiological study can have broad implications for human health."